logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/06/2025
On June 20th, local time, Meta and Essilor announced the launch of a new Oakley Meta HSTN smart glasses with a starting price of $399. Meta stated that these new smart glasses use Oakley's PRIZM Lens technology, designed to help athletes achieve a clearer vision in constantly changing light and weather conditions. (First Finance).
Latest
9 m ago
Tesla invites a select few to participate in a test of autonomous taxi equipped with front seat safety monitors in the state of Texas.
9 m ago
Tesla invited a small number of people to participate in a trial of autonomous taxis equipped with front seat safety monitors in Texas.
10 m ago
Court documents show that Apple shareholders have filed a class-action lawsuit claiming that Apple underestimated the amount of time needed to introduce artificial intelligence features to Siri.
10 m ago
Court documents show that Apple shareholders have filed a class-action lawsuit, alleging that Apple underestimated the time needed to introduce artificial intelligence capabilities for Siri.
17 m ago
According to the latest guidelines from the American College of Cardiology (ACC), GLP-1 and other Nutrient Stimulated Hormones (NuSH) should be used to aid in weight loss before making lifestyle changes to prevent heart disease. Canadian Montreal Bank (BMO) analyst Evan Seigerman states that the new recommendations may signify a "paradigm shift in the way that doctors think about treating obesity and preventing heart disease." The analyst states that the ACC emphasizes their "new stance that patients should not be required to undergo lifestyle intervention before receiving NuSH therapy." He writes, "This shift in recommendation may open the doors for a wider coverage of these drugs without the need for gradual lifestyle changes." He suggests that this could lead to "increased pressure on future insurance plans."
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.